SCHEMBL10734445

SCHEMBL10734445

C[S+]([O-])c1ccc(C(=O)Cn2cc(Cl)cnc2=O)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.43
LMNA P02545 1/20 0.40
RAB9A P51151 4/20 0.39
ALDH1A1 P00352 4/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
NPC1 O15118 2/20 0.39
TSHR P16473 1/20 0.39
STAT1 P42224 1/20 0.39
P2RX7 Q99572 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
PKM P14618 1/20 0.37
MAPT P10636 4/20 0.36
HTT P42858 2/20 0.36
MITF O75030 1/20 0.36
S1PR4 O95977 1/20 0.36
TP53 P04637 1/20 0.36
S1PR1 P21453 1/20 0.36
POLB P06746 2/20 0.36
MCHR1 Q99705 1/20 0.36
KDM4E B2RXH2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10738569 0.84 KMT2A (0.51) KMT2ALMNARAB9AALDH1A1SMN1; SMN2
SCHEMBL10733675 0.83 PKM (0.49) KMT2ALMNARAB9AALDH1A1SMN1; SMN2
SCHEMBL10738872 0.82 HSD17B10 (0.47) KMT2ALMNARAB9AALDH1A1SMN1; SMN2
SCHEMBL10731997 0.82 KMT2A (0.43) KMT2ALMNARAB9AALDH1A1SMN1; SMN2
SCHEMBL10735695 0.81 KMT2A (0.44) KMT2ALMNARAB9AALDH1A1SMN1; SMN2
SCHEMBL10738470 0.81 F2 (0.47) KMT2ALMNARAB9AALDH1A1SMN1; SMN2
SCHEMBL10740587 0.81 RAB9A (0.48) KMT2ALMNARAB9AALDH1A1SMN1; SMN2
SCHEMBL10733533 0.80 POLB (0.55) KMT2ARAB9AALDH1A1SMN1; SMN2NPC1
SCHEMBL10734700 0.80 NPC1 (0.51) KMT2ALMNARAB9AALDH1A1NPC1
SCHEMBL10821523 0.80 KMT2A (0.42) KMT2ALMNARAB9AALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4636509-A Substituted pyrimidin-2-ones, the salts thereof, processes for their preparation, pharmaceutical compositions containing them and a method therefor GLAXO GROUP LIMITED (GB) 1987-01-13 US disclosed
EP-0044704-B1 SUBSTITUTED PYRIMIDIN-2-ONES, THE SALTS THEREOF, PROCESSES FOR THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM GLAXO GROUP LIMITED (GB) 1986-05-07 EP disclosed
EP-0044704-A1 Substituted pyrimidin-2-ones, the salts thereof, processes for their preparation, and pharmaceutical compositions containing them GLAXO GROUP LIMITED (GB) 1982-01-27 EP disclosed